| zonisamide / Generic mfg. |
NCT00650052: Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg |
|
|
| Completed | 1 | 107 | US | Zonisamide Capsules 100 mg, Zonegran® Capsules 100 mg | Mylan Pharmaceuticals Inc | Healthy | 12/03 | 12/03 | | |
NCT00649714: Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg |
|
|
| Completed | 1 | 110 | US | Zonisamide Capsules 100 mg, Zonegran® Capsules 100 mg | Mylan Pharmaceuticals Inc | Healthy | 01/04 | 01/04 | | |
NCT01161966: Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions |
|
|
| Completed | 1 | 26 | US | Zonisamide, Zonegran Capsules 100 mg, Zonegran | Dr. Reddy's Laboratories Limited | Healthy | 02/05 | 03/05 | | |
NCT01161979: Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions |
|
|
| Completed | 1 | 26 | US | Zonisamide, Zonegran Capsules 100 mg, Zonegran | Dr. Reddy's Laboratories Limited | Healthy | 02/05 | 03/05 | | |
NCT00685139: Fasting Bioavailability Study of Zonisamide Capsules |
|
|
| Completed | 1 | 34 | US | Zonisamide 100 mg Capsule, Zonisamide (Zonegran®) 100 mg Capsule, Zonegran® | Mutual Pharmaceutical Company, Inc. | Healthy | 03/05 | 03/05 | | |
NCT00687167: Fed Bioavailability Study of Zonisamide Capsules |
|
|
| Completed | 1 | 34 | US | Zonisamide 100 mg Capsule, Zonisamide (Zonegran®) 100 mg Capsule, Zonegran® | Mutual Pharmaceutical Company, Inc. | Healthy | 03/05 | 03/05 | | |
